Pharmacist-driven CGM Use in the Uninsured Population

Virginia Commonwealth University (VCU)

Status: Completed

Conditions: Diabetes Mellitus

Treatments: Device: FreeStyle LibrePro CGM

Study type: Interventional

Funder types: Other

Identifiers

NCT03477838

HM20012049

Details and patient eligibility

About

This is a pilot study. The purpose is to (1) provide access to continuous glucose monitoring (CGM) to patients (purchased through a grant) and (2) systematically record and analyze the results of the glucose monitoring by the clinical pharmacists at the clinic.

Enrollment: 28 patients

Sex: All

Ages: 18 to 89 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. adult 18 years of age or older
2. diagnosis of Type 1 or Type 2 diabetes
3. A1c greater than 8%
4. prescribed basal insulin plus either prandial insulin or a glucagon-like peptide-1 (GLP-1) receptor agonist

Exclusion criteria

1. pregnant or breast-feeding
2. on dialysis
3. not appropriate for CGM use based on clinical judgment by the investigators
4. patients with limited English proficiency

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

28 participants in 1 patient group

CGM Intervention arm

Experimental group

Description:

Patients eligible for care at the free clinic with diabetes and A1c greater than 8% on insulin therapy will be identified for CGM use.

Treatment:

Device: FreeStyle LibrePro CGM